Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-08 | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN
(CEO) |
S | Common Stock | D | 26574 | $17.87 - $17.87 | $474,876 |
| 2024-04-08 | ACADIA PHARMACEUTICALS INC | Teehan Brendan
(EVP, COO, HEAD OF COMMERCIAL) |
S | Common Stock | D | 2568 | $17.87 - $17.87 | $45,890 |
| 2024-04-08 | ACADIA PHARMACEUTICALS INC | Schneyer Mark C.
(EVP, CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 2716 | $17.87 - $17.87 | $48,534 |
| 2024-03-27 | ACADIA PHARMACEUTICALS INC | Teehan Brendan
(EVP, COO, HEAD OF COMMERCIAL) |
S | Common Stock | D | 5140 | $17.90 - $17.90 | $92,005 |
| 2024-03-25 | ACADIA PHARMACEUTICALS INC | Teehan Brendan
(EVP, COO, HEAD OF COMMERCIAL) |
A | Common Stock | A | 10048 | $0.00 - $0.00 | $0 |
| 2024-03-27 | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN
(CEO) |
S | Common Stock | D | 17714 | $17.90 - $17.90 | $317,080 |
| 2024-03-25 | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN
(CEO) |
A | Common Stock | A | 34666 | $0.00 - $0.00 | $0 |
| 2024-03-27 | ACADIA PHARMACEUTICALS INC | Schneyer Mark C.
(EVP, CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 5434 | $17.90 - $17.90 | $97,268 |
| 2024-03-25 | ACADIA PHARMACEUTICALS INC | Schneyer Mark C.
(EVP, CHIEF FINANCIAL OFFICER) |
A | Common Stock | A | 10550 | $0.00 - $0.00 | $0 |
| 2024-02-26 | ACADIA PHARMACEUTICALS INC | Schneyer Mark C.
(EVP, CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 772 | $24.67 - $24.67 | $19,045 |
| 2024-02-26 | ACADIA PHARMACEUTICALS INC | Kihara James
(PRINCIPAL ACCOUNTING OFFICER) |
S | Common Stock | D | 474 | $24.67 - $24.67 | $11,693 |
| 2024-02-26 | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN
(CEO) |
S | Common Stock | D | 5577 | $24.67 - $24.67 | $137,584 |
| 2024-01-08 | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN
(CEO) |
S | Common Stock | D | 3732 | $29.96 - $29.96 | $111,810 |
| 2024-01-08 | ACADIA PHARMACEUTICALS INC | Teehan Brendan
(EVP, COO, Head of Commercial) |
S | Common Stock | D | 731 | $29.96 - $29.96 | $21,900 |
| 2024-01-08 | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D.
(EVP,General Counsel, Secretary) |
S | Common Stock | D | 590 | $29.96 - $29.96 | $17,676 |
| 2023-12-15 | ACADIA PHARMACEUTICALS INC | Kihara James
(Principal Accounting Officer) |
S | Common Stock | D | 2000 | $28.30 - $28.30 | $56,600 |
| 2023-11-20 | ACADIA PHARMACEUTICALS INC | Teehan Brendan
(EVP, COO, Head of Commercial) |
S | Common Stock | D | 4960 | $22.64 - $22.64 | $112,294 |
| 2023-11-20 | ACADIA PHARMACEUTICALS INC | Schneyer Mark C.
(EVP, Chief Financial Officer) |
S | Common Stock | D | 5108 | $22.64 - $22.64 | $115,645 |
| 2023-11-20 | ACADIA PHARMACEUTICALS INC | Kihara James
(Principal Accounting Officer) |
S | Common Stock | D | 1985 | $22.64 - $22.64 | $44,940 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |